Abstract
IDOL (inducible degrader of the low-density lipoprotein receptor, LDLR) is an E3 ubiquitin ligase that promotes the ubiquitination and degradation of the LDLR. IDOL is a potential therapeutic target for the development of a novel class of low-density lipoprotein cholesterol (LDL-C)-lowering therapies. In an attempt to develop a mouse model for testing IDOL inhibitors, we examined the effects of adeno-associated virus (AAV)-mediated stable expression of human IDOL in the livers of mice 'humanized' with regard to lipoprotein metabolism. Using a liver-specific AAV serotype 8 (AAV8)-mediated delivery, AAV-hIDOL produced a dose-dependent increase in LDL-C levels and a decrease in liver LDLR protein. Furthermore, we expressed hIDOL in a 'humanized' mouse model of heterozygous familial hypercholesterolaemia (LDLR(+/-)/Apobec1(-/-)/hApoB-Tg, LAhB). In this model, total cholesterol (TC) and LDL-C levels were increased by ∼60% starting from 1 week and were sustainable for at least 3 weeks post-injection. Finally, we demonstrate that the effects caused by hIDOL expression are LDLR- dependent given the unchanged plasma lipids in LAhB mice lacking LDLR. In conclusion, our study demonstrates a dose-dependent physiological effect of human IDO...Continue Reading
References
Feb 2, 1996·The Journal of Biological Chemistry·T L InnerarityS O Olofsson
Jun 13, 2009·Science·Noam ZelcerPeter Tontonoz
Apr 30, 2010·The Journal of Biological Chemistry·Cynthia HongNoam Zelcer
Jun 22, 2010·Journal of Lipid Research·Minako IshibashiAlan R Tall
Aug 6, 2010·Nature·Tanya M TeslovichSekar Kathiresan
Sep 25, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Dawn M WaterworthManjinder S Sandhu
Jul 19, 2011·The Journal of Clinical Investigation·Daphna Weissglas-VolkovPäivi Pajukanta
Sep 1, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Li ZhangPeter Tontonoz
Sep 19, 2012·Human Gene Therapy·Sadik H KassimDaniel J Rader
Jan 18, 2013·European Heart Journal·Vincenzo SorrentinoNoam Zelcer
Oct 8, 2013·Nature Genetics·Cristen J WillerUNKNOWN Global Lipids Genetics Consortium
Jul 16, 2014·Circulation Research·Suryanarayan SomanathanDaniel J Rader
Dec 2, 2014·The Journal of Clinical Investigation·Geun Hyang KimSeung-Whan Kim
Dec 3, 2014·Cell Metabolism·Cynthia HongPeter Tontonoz
Citations
Mar 30, 2018·Circulation·May E MontasserYen-Pei C Chang
Aug 22, 2017·Nature Medicine·Sumeet A KhetarpalDaniel J Rader
Mar 22, 2019·Current Opinion in Lipidology·Nienke M van LoonNoam Zelcer
Jul 28, 2018·Frontiers in Pharmacology·Maria MytilinaiouHarpal S Randeva
Oct 11, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Dilare AdiJie Luo
Nov 21, 2017·The American Journal of Pathology·Karin E BornfeldtJenny E Kanter
May 21, 2021·Vascular Pharmacology·Qi YuYaping Zhang